Karim Chamie, MD

UCLA

Karim Chamie, MD, MSHS, is an Associate Professor of Urology at UCLA. He attended Medical School at USC, completed urological training at UC Davis, and a SUO certified fellowship in Urologic Oncology and Health Services Research at UCLA. His primary research interests are health services research and clinical trials in bladder cancer. His clinical interests include all areas of urologic oncology, with a particular emphasis on urothelial carcinoma and robotic surgery. He is the Director of Society of Urologic Oncology Fellowship at UCLA.

Disclosure information not submitted.

Presentation(s):

• Late-Breaking Abstract: PLLBA-01: Final clinical results of pivotal trial of IL-15R&[alpha]Fc superagonist N-803 with BCG in BCG-unresponsive non-muscle invasive bladder cancer (NMIBC) CIS and Papillary Cohorts

  Friday, May 13, 2022
  10:45 AM – 10:55 AM

• PLLBA-01: Final clinical results of pivotal trial of IL-15RαFc superagonist N-803 with BCG in BCG-unresponsive non-muscle invasive bladder cancer (NMIBC) CIS

  Friday, May 13, 2022
  11:05 AM – 11:13 AM

• A Treatment Option for Patients with Urothelial Carcinoma in the Adjuvant Setting

  Saturday, May 14, 2022
  12:30 PM – 1:30 PM

• MP42: Bladder Cancer: Epidemiology & Evaluation II

  Sunday, May 15, 2022
  10:30 AM – 11:45 AM